PF-232798 is under investigation in clinical trial NCT01140425 (Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.